News | November 30, 2022
Biocon Biologics completes acquisition of Viatris' Global Biosimilars Business
To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan
To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan
Total investment envisaged in this project stands at up to Rs 70 crore
The company offers a wide portfolio of services including integrated doctor-led prescription e-commerce enablement, digital health record management, and smart clinics.
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
CEPI will provide up to US$40 million in initial funding to support the development of mRNA-vaccine candidates against Lassa Fever virus
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
The two-day meeting in the city was organized in collaboration with the University of Birmingham, Christian Medical College Ludhiana, and Birmingham Clinical Trials Unit
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
Olympus Corp was the market leader for endoscopy devices, accounting for around 23% of the global market in 2021.
Subscribe To Our Newsletter & Stay Updated
